Pembrolizumab-Associated Unilateral Optic Neuritis

참고문헌 (9)

1. Yu CW, "Neuro-ophthalmic complications of immune checkpoint inhibitors : a systematic review", Eye Brain, 12, pp.139~167 (2020)
2. Makri OE, "Isolated optic neuritis after pembrolizumab administration for non-small-cell lung carcinoma", Int J Neurosci, 132, pp.643~648 (2022)
3. Francis JH, "Immune checkpoint inhibitor-associated optic neuritis", Ophthalmology, 127, pp.1585~1589 (2020)
4. Hahn L, "Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma", J Ophthalmic Inflamm Infect, 6, pp.14~ (2016)
5. Morgado M, "Management of the adverse effects of immune checkpoint inhibitors", Vaccines(Basel), 8, pp.575~ (2020)
6. Fortes BH, "Ophthalmic adverse effects of immune checkpoint inhibitors : the Mayo Clinic experience", Br J Ophthalmol, 105, pp.1263~1271 (2021)
7. Kim JM, "Ophthalmic immune-related adverse events of immunotherapy : a single-site case series", Ophthalmology, 126, pp.1058~1062 (2019)
8. Mori S, "Optic neuritis possibly induced by anti-PD-L1 antibody treatment in a patient with non-small cell lung carcinoma", Case Rep Ophthalmol, 9, pp.348~356 (2018)
9. Wright JJ, "Endocrine toxicities of immune checkpoint inhibitors", Nat Rev Endocrinol, 17, pp.389~399 (2021)

관련 논문AI추천